Agriculture Plastic Residues Are Poisoning Soils, Food Systems & Threatening Human Health, Says FAO 10/12/2021 Raisa Santos Agricultural plastics pose large and growing threat to soils, food safety and human health – and need to be better managed as well as replaced with more sustainable alternatives, as well as more recycling and reuse of plastics consumed. These are the findings of a new report by the UN Food and Agriculture Organization, “Assessment […] Continue reading -> US Announces ‘Global VAX’ to Push COVID-19 Vaccination Effort Worldwide 07/12/2021 Editorial team The US Agency for International Development (USAID) has set up a new global initiative to accelerate COVID-19 vaccination efforts, called the Initiative for Global Vaccine Access (Global VAX), the agency announced on Monday Global Vax’s aim according to USAID, is to “get COVID-19 shots into arms and enhance international coordination to identify and rapidly overcome […] Continue reading -> As Omicron Detected in Canada, Brazil and US, PAHO Calls for Increased Genomic Surveillance 03/12/2021 Raisa Santos Following the detection of the newest WHO COVID-19 variant of concern, Omicron, in Canada and Brazil, and most recently, the US, the Pan American Health Organization (PAHO) has urged countries to “redouble their surveillance efforts in the region, warning that it is likely that the new variant will likely be circulating in other parts of […] Continue reading -> C-TAP and Medicines Patent Pool Announce Global License for Spanish COVID-19 Test 23/11/2021 Raisa Santos The first non-exclusive license for a COVID-19 health tool – a serological antibody test that checks for the presence of anti-SARS-CoV-2 antibodies – has been finalised by the World Health Organization’s (WHO) COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP). The license, announced on Tuesday in partnership with the Spanish National Research […] Continue reading -> Traffic Crash Remembrance Day: Grieving Parents Urge Better Road Safety Policies 22/11/2021 Kerry Cullinan Two parents who lost their children in car crashes urged governments to adopt better road safety policies on the World Day of Remembrance for Road Traffic Victims on Monday. South African Zoleka Mandela’s daughter died in a Johannesburg crash on her 13th birthday, while Australian Peter Frazer’s 23-year-old daughter was killed by a truck on […] Continue reading -> UK Approves Long-acting HIV Injectable Antiretroviral Treatment 19/11/2021 Raisa Santos People living with HIV in England and Wales may be eligible for injectable antiretroviral treatment every two months, rather than daily pills. Two injectable drugs, cabotegravir and rilpivirine, were recommended for use by the UK National Institute for Health and Care (NICE) on Thursday after trials proved they work as effectively as daily tablets, according […] Continue reading -> Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> WHO Wants More Diversity for SARS-CoV2 Origins Group, While US NGO Calls for ‘Conflicted’ Scientists to be Removed 03/11/2021 Kerry Cullinan A US organisation that promotes transparency in health policy decisions, Right to Know, has asked the World Health Organization (WHO) to remove 10 of the 26 candidates it had recently named to a new Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) – due to alleged conflicts of interest – and replace them […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US Announces ‘Global VAX’ to Push COVID-19 Vaccination Effort Worldwide 07/12/2021 Editorial team The US Agency for International Development (USAID) has set up a new global initiative to accelerate COVID-19 vaccination efforts, called the Initiative for Global Vaccine Access (Global VAX), the agency announced on Monday Global Vax’s aim according to USAID, is to “get COVID-19 shots into arms and enhance international coordination to identify and rapidly overcome […] Continue reading -> As Omicron Detected in Canada, Brazil and US, PAHO Calls for Increased Genomic Surveillance 03/12/2021 Raisa Santos Following the detection of the newest WHO COVID-19 variant of concern, Omicron, in Canada and Brazil, and most recently, the US, the Pan American Health Organization (PAHO) has urged countries to “redouble their surveillance efforts in the region, warning that it is likely that the new variant will likely be circulating in other parts of […] Continue reading -> C-TAP and Medicines Patent Pool Announce Global License for Spanish COVID-19 Test 23/11/2021 Raisa Santos The first non-exclusive license for a COVID-19 health tool – a serological antibody test that checks for the presence of anti-SARS-CoV-2 antibodies – has been finalised by the World Health Organization’s (WHO) COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP). The license, announced on Tuesday in partnership with the Spanish National Research […] Continue reading -> Traffic Crash Remembrance Day: Grieving Parents Urge Better Road Safety Policies 22/11/2021 Kerry Cullinan Two parents who lost their children in car crashes urged governments to adopt better road safety policies on the World Day of Remembrance for Road Traffic Victims on Monday. South African Zoleka Mandela’s daughter died in a Johannesburg crash on her 13th birthday, while Australian Peter Frazer’s 23-year-old daughter was killed by a truck on […] Continue reading -> UK Approves Long-acting HIV Injectable Antiretroviral Treatment 19/11/2021 Raisa Santos People living with HIV in England and Wales may be eligible for injectable antiretroviral treatment every two months, rather than daily pills. Two injectable drugs, cabotegravir and rilpivirine, were recommended for use by the UK National Institute for Health and Care (NICE) on Thursday after trials proved they work as effectively as daily tablets, according […] Continue reading -> Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> WHO Wants More Diversity for SARS-CoV2 Origins Group, While US NGO Calls for ‘Conflicted’ Scientists to be Removed 03/11/2021 Kerry Cullinan A US organisation that promotes transparency in health policy decisions, Right to Know, has asked the World Health Organization (WHO) to remove 10 of the 26 candidates it had recently named to a new Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) – due to alleged conflicts of interest – and replace them […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
As Omicron Detected in Canada, Brazil and US, PAHO Calls for Increased Genomic Surveillance 03/12/2021 Raisa Santos Following the detection of the newest WHO COVID-19 variant of concern, Omicron, in Canada and Brazil, and most recently, the US, the Pan American Health Organization (PAHO) has urged countries to “redouble their surveillance efforts in the region, warning that it is likely that the new variant will likely be circulating in other parts of […] Continue reading -> C-TAP and Medicines Patent Pool Announce Global License for Spanish COVID-19 Test 23/11/2021 Raisa Santos The first non-exclusive license for a COVID-19 health tool – a serological antibody test that checks for the presence of anti-SARS-CoV-2 antibodies – has been finalised by the World Health Organization’s (WHO) COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP). The license, announced on Tuesday in partnership with the Spanish National Research […] Continue reading -> Traffic Crash Remembrance Day: Grieving Parents Urge Better Road Safety Policies 22/11/2021 Kerry Cullinan Two parents who lost their children in car crashes urged governments to adopt better road safety policies on the World Day of Remembrance for Road Traffic Victims on Monday. South African Zoleka Mandela’s daughter died in a Johannesburg crash on her 13th birthday, while Australian Peter Frazer’s 23-year-old daughter was killed by a truck on […] Continue reading -> UK Approves Long-acting HIV Injectable Antiretroviral Treatment 19/11/2021 Raisa Santos People living with HIV in England and Wales may be eligible for injectable antiretroviral treatment every two months, rather than daily pills. Two injectable drugs, cabotegravir and rilpivirine, were recommended for use by the UK National Institute for Health and Care (NICE) on Thursday after trials proved they work as effectively as daily tablets, according […] Continue reading -> Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> WHO Wants More Diversity for SARS-CoV2 Origins Group, While US NGO Calls for ‘Conflicted’ Scientists to be Removed 03/11/2021 Kerry Cullinan A US organisation that promotes transparency in health policy decisions, Right to Know, has asked the World Health Organization (WHO) to remove 10 of the 26 candidates it had recently named to a new Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) – due to alleged conflicts of interest – and replace them […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
C-TAP and Medicines Patent Pool Announce Global License for Spanish COVID-19 Test 23/11/2021 Raisa Santos The first non-exclusive license for a COVID-19 health tool – a serological antibody test that checks for the presence of anti-SARS-CoV-2 antibodies – has been finalised by the World Health Organization’s (WHO) COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP). The license, announced on Tuesday in partnership with the Spanish National Research […] Continue reading -> Traffic Crash Remembrance Day: Grieving Parents Urge Better Road Safety Policies 22/11/2021 Kerry Cullinan Two parents who lost their children in car crashes urged governments to adopt better road safety policies on the World Day of Remembrance for Road Traffic Victims on Monday. South African Zoleka Mandela’s daughter died in a Johannesburg crash on her 13th birthday, while Australian Peter Frazer’s 23-year-old daughter was killed by a truck on […] Continue reading -> UK Approves Long-acting HIV Injectable Antiretroviral Treatment 19/11/2021 Raisa Santos People living with HIV in England and Wales may be eligible for injectable antiretroviral treatment every two months, rather than daily pills. Two injectable drugs, cabotegravir and rilpivirine, were recommended for use by the UK National Institute for Health and Care (NICE) on Thursday after trials proved they work as effectively as daily tablets, according […] Continue reading -> Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> WHO Wants More Diversity for SARS-CoV2 Origins Group, While US NGO Calls for ‘Conflicted’ Scientists to be Removed 03/11/2021 Kerry Cullinan A US organisation that promotes transparency in health policy decisions, Right to Know, has asked the World Health Organization (WHO) to remove 10 of the 26 candidates it had recently named to a new Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) – due to alleged conflicts of interest – and replace them […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Traffic Crash Remembrance Day: Grieving Parents Urge Better Road Safety Policies 22/11/2021 Kerry Cullinan Two parents who lost their children in car crashes urged governments to adopt better road safety policies on the World Day of Remembrance for Road Traffic Victims on Monday. South African Zoleka Mandela’s daughter died in a Johannesburg crash on her 13th birthday, while Australian Peter Frazer’s 23-year-old daughter was killed by a truck on […] Continue reading -> UK Approves Long-acting HIV Injectable Antiretroviral Treatment 19/11/2021 Raisa Santos People living with HIV in England and Wales may be eligible for injectable antiretroviral treatment every two months, rather than daily pills. Two injectable drugs, cabotegravir and rilpivirine, were recommended for use by the UK National Institute for Health and Care (NICE) on Thursday after trials proved they work as effectively as daily tablets, according […] Continue reading -> Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> WHO Wants More Diversity for SARS-CoV2 Origins Group, While US NGO Calls for ‘Conflicted’ Scientists to be Removed 03/11/2021 Kerry Cullinan A US organisation that promotes transparency in health policy decisions, Right to Know, has asked the World Health Organization (WHO) to remove 10 of the 26 candidates it had recently named to a new Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) – due to alleged conflicts of interest – and replace them […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
UK Approves Long-acting HIV Injectable Antiretroviral Treatment 19/11/2021 Raisa Santos People living with HIV in England and Wales may be eligible for injectable antiretroviral treatment every two months, rather than daily pills. Two injectable drugs, cabotegravir and rilpivirine, were recommended for use by the UK National Institute for Health and Care (NICE) on Thursday after trials proved they work as effectively as daily tablets, according […] Continue reading -> Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> WHO Wants More Diversity for SARS-CoV2 Origins Group, While US NGO Calls for ‘Conflicted’ Scientists to be Removed 03/11/2021 Kerry Cullinan A US organisation that promotes transparency in health policy decisions, Right to Know, has asked the World Health Organization (WHO) to remove 10 of the 26 candidates it had recently named to a new Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) – due to alleged conflicts of interest – and replace them […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Moderna Disputes That US Government Scientists Co-invented COVID mRNA Vaccine 12/11/2021 Raisa Santos Moderna has fired back against claims made by US National Institutes of Health (NIH) that its scientists at the National Institute of Allergy and Infectious Diseases (NIAD) helped to invent the crucial component of the pharma company’s COVID-19 vaccine, stating that the mRNA sequence was “selected exclusively” by Moderna scientists. “We do not agree that […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> WHO Wants More Diversity for SARS-CoV2 Origins Group, While US NGO Calls for ‘Conflicted’ Scientists to be Removed 03/11/2021 Kerry Cullinan A US organisation that promotes transparency in health policy decisions, Right to Know, has asked the World Health Organization (WHO) to remove 10 of the 26 candidates it had recently named to a new Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) – due to alleged conflicts of interest – and replace them […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> WHO Wants More Diversity for SARS-CoV2 Origins Group, While US NGO Calls for ‘Conflicted’ Scientists to be Removed 03/11/2021 Kerry Cullinan A US organisation that promotes transparency in health policy decisions, Right to Know, has asked the World Health Organization (WHO) to remove 10 of the 26 candidates it had recently named to a new Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) – due to alleged conflicts of interest – and replace them […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Wants More Diversity for SARS-CoV2 Origins Group, While US NGO Calls for ‘Conflicted’ Scientists to be Removed 03/11/2021 Kerry Cullinan A US organisation that promotes transparency in health policy decisions, Right to Know, has asked the World Health Organization (WHO) to remove 10 of the 26 candidates it had recently named to a new Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) – due to alleged conflicts of interest – and replace them […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Posts navigation Older Posts Newer Posts